medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2023, Number 12

<< Back

Ginecol Obstet Mex 2023; 91 (12)

Use of an intra-aortic balloon pump in Obstetrics. Case report

Rubio-Arroyo MM, Ruiz de Santaquiteria-Torres V, Barrera-Coello L, Martín-Gómez M, Crespo-Criado M, Cancelo-Hidalgo MJ

Language: Spanish
References: 16
Page: 914-917
PDF size: 178.75 Kb.


ABSTRACT

Background: Anomalies of placental insertion are becoming increasingly common. Prevention of blood loss with intra-aortic counterpulsation balloons is a useful option in the care of pregnant patients.
Clinical cases: 38-year-old pregnant woman with a history of euthyroid delivery and no medical or surgical history. Prenatal follow-up was initiated at 17 weeks, with a delay in diagnosis due to the fact that she was still on contraceptive treatment. Trophoblastic invasion was limited to the myometrium with no evidence of invasion into adjacent organs. The patient was counseled on the potential complications to minimize the risk of massive, potentially fatal hemorrhage at delivery. As the patient did not wish to become pregnant again, a post-cesarean hysterectomy was recommended, leaving the placenta in situ.
Conclusions: Endovascular occlusion with intra-aortic balloon counterpulsation is a safe and effective option to minimize blood loss in cases of placental insertion anomalies. In addition to the classical femoral approach, the axillary route can be used with equal efficacy. The low rate of maternal complications and the safety with respect to fetal irradiation make it a reasonable option in the management of pregnant patients in whom high blood loss is expected.


REFERENCES

  1. Jauniaux E, Alfirevic Z, Bhide AG, Belfort MA, et al. Placentapraevia and placenta accreta: diagnosis and management:green-top Guideline No. 27a. BJOG 2019; 126 (1): e1e48.https://doi.org/10.1111/1471-0528.15306

  2. Hobson SR, Kingdom JC, Murji A, Windrim RC, et al. No.383-Screening, diagnosis, and management of placentaaccreta spectrum disorders. J Obstet Gynaecol Can2019; 41 (7): 1035-1049. https://doi.org/10.1016/j.jogc.2018.12.004

  3. González-Merlo J. Obstetricia. In: Obstetricia. 7a Edición;2018. p. 409-19.

  4. Osborn LA, Brenner ML, Prater SJ, Moore LJ. Resuscitativeendovascular balloon occlusion of the aorta: current evidence.Open Access Emerg Med 2019; 11: 29-38. https://doi.org/10.2147/OAEM.S166087

  5. Ordoñez CA, Manzano-Nunez R, Parra MW, RasmussenTE, et al. Prophylactic use of resuscitative endovascularballoon occlusion of the aorta in women with abnormalplacentation: A systematic review, meta-analysis, and caseseries. J Trauma Acute Care Surg 2018; 84 (5): 809-818.https://doi.org/10.1097/TA.0000000000001821

  6. Paull JD, Smith J, Williams L, Davison G, et al. Balloonocclusion of the abdominal aorta during caesareanhysterectomy for placenta percreta. AnaesthIntensive Care 1995; 23 (6): 731-734. https://doi.org/10.1177/0310057X9502300616

  7. Manzano-Nunez R, Escobar-Vidarte MF, Naranjo MP, RodriguezF, et al. Expanding the field of acute care surgery: asystematic review of the use of resuscitative endovascularballoon occlusion of the aorta (REBOA) in cases of morbidlyadherent placenta. Eur J Trauma Emerg Surg 2018; 44 (4):519-526. https://doi.org/10.1007/s00068-017-0840-4

  8. Wang YL, Duan XH, Han XW, Wang L, et al. Comparison oftemporary abdominal aortic occlusion with internal iliacartery occlusion for patients with placenta accreta - a nonrandomisedprospective study. Vasa 2017; 46 (1): 53-57.https://doi.org/10.1024/0301-1526/a000577

  9. Zhu H, Wang S, Shi J, Yao L, et al. Prophylactic endovascularballoon occlusion of the aorta in cases of placentaaccreta spectrum during caesarean section: points fromthe anaesthesiologist's perspective. BMC PregnancyChildbirth 2020; 20 (1): 446. https://doi.org/10.1186/s12884-020-03136-y

  10. Duan XH, Wang YL, Han XW, Chen ZM, et al. Caesareansection combined with temporary aortic balloon occlusionfollowed by uterine artery embolisation for the managementof placenta accreta. Clin Radiol 2015; 70 (9): 932-937.https://doi.org/10.1016/j.crad.2015.03.008

  11. Masamoto H, Uehara H, Gibo M, Okubo E, et al. Electiveuse of aortic balloon occlusion in cesarean hysterectomyfor placenta previa percreta. Gynecol Obstet Invest 2009;67 (2): 92-95. https://doi.org/10.1159/000164685

  12. Chou MM, Ke YM, Wu HC, Tsai CP, et al. Temporarycross-clamping of the infrarenal abdominal aorta duringcesarean hysterectomy to control operative blood loss inplacenta previa increta/percreta. Taiwan J Obstet Gynecol2010; 49 (1): 72-76. https://doi.org/10.1016/S1028-4559(10)60013-7

  13. Wei X, Zhang J, Chu Q, Du Y, et al. Prophylactic abdominalaorta balloon occlusion during caesarean section: a retrospectivecase series. Int J Obstet Anesth 2016; 27: 3-8.https://doi.org/10.1016/j.ijoa.2015.12.001

  14. Patel NB, Plaat F. Should women be able to choose caesareandelivery? A survey of UK obstetric anaesthetists.Int J Obstet Anesth 2014; 23 (1): 90-91. doi: 10.1016/j.ijoa.2013.08.005.

  15. Luo Y, Duan H, Liu W, Min L, et al. Clinical evaluation forlower abdominal aorta balloon occluding in the pelvic andsacral tumor resection. J Surg Oncol 2013; 108 (3): 148-151.https://doi.org/10.1002/jso.23376

  16. Nieto-Calvache AJ, Salas LF, Duran EJ, Benavides SO, etal. Estimation of fetal radiation absorbed dose during theprophylactic use of aortic occlusion balloon for abnormallyinvasive placenta. J Matern Fetal Neonatal Med 2021; 34(19): 3181-3186. https://doi.org/10.1080/14767058.2019.1678144




2020     |     www.medigraphic.com